NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001721

Registered date:20/02/2009

Prospective phase II study of stereotactic body radiation therapy using helical tomotherapy for stage IA non-small cell lung cancer.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedstage IA non-small cell lung cancer
Date of first enrollment2009/02/20
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)patient number 50, accrual 4 years, follow-up 3years stereotactic body radiation therapy 60Gy/6fraction/8-12 days

Outcome(s)

Primary Outcome3-year overall survival rate
Secondary Outcomeoverall survival time, relapse-free survival time, local pregression-free survival time, 3-year local progression free rate, type of recurrence, acute adverse event, late adverse event, ratio of severe adverse event

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriainterstitial pneumonitis, lung fibrosis active infection active multiple cancer (last 3 years) pregnancy or breast feeding psychological disorder systemic steroid medication

Related Information

Contact

public contact
Name Natsuo Tomita
Address 1-1 Kanoko-den, Chikusa-ku 464-8681, Nagoya, Aichi Japan
Telephone 052-762-6111
E-mail ntomita@aichi-cc.jp
Affiliation Aichi Cancer Center Hospital Department of Therapeutic Radiation Oncology
scientific contact
Name Takeshi Kodaira
Address 1-1 Kanoko-den, Chikusa-ku 464-8681, Nagoya, Aichi Japan
Telephone 052-762-6111
E-mail 109103@aichi-cc.jp
Affiliation Aichi Cancer Center Hospital Department of Therapeutic Radiation Oncology